[Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000517:prevention & control*; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D007933:Leucomycins; D013411:Sulfadiazine; D011739:Pyrimethamine
Aangeboren toxoplasmose; kanttekeningen bij het advies van de Gezondheidsraad.